Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Yu Fan

Q3 2024 · 13F-HR

Yu Fanholdings as filed

Filed 2024-11-14 · accession 0000950123-24-011471

$32.5M
Reported value
6
Positions
2024-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
14179K101CRGXCARGO THERAPEUTICS INC$16.8M51.8%912,000CommonSOLE
022307102ALMSALUMIS INC$8.4M26.0%789,618CommonSOLE
156944100CGONCG ONCOLOGY INC$6.2M19.0%163,456CommonSOLE
14843C105CSTLCASTLE BIOSCIENCES INC$641,7861.98%22,503CommonSOLE
747324101PYXSPYXIS ONCOLOGY INC$254,3420.78%69,303CommonSOLE
786700104SGMTSAGIMET BIOSCIENCES INC$158,4160.49%57,190CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.